U.S. Marine and Shipping Stock News

NYSE:EPAM
NYSE:EPAMIT

Is It Time To Reassess EPAM Systems (EPAM) After Prolonged Share Price Weakness

If you are wondering whether EPAM Systems is starting to look attractively priced, you are not alone. The recent share performance has many investors reassessing what the stock is really worth. The share price closed at US$167.69, with returns of a 5.8% decline over 7 days, 21.1% decline over 30 days, 16.3% decline year to date, 35.0% decline over 1 year, 46.1% decline over 3 years and 54.6% decline over 5 years. Recent headlines around EPAM Systems have focused on its role as a global...
NYSE:FDX
NYSE:FDXLogistics

FedEx Business Model Shift Puts Margins Valuation And Debt In Focus

FedEx (NYSE:FDX) is shifting its focus toward higher margin B2B logistics and premium direct-to-consumer services, while restructuring operations under its unified One FedEx model. The company is introducing new surcharges, ending certain last mile e-commerce subsidies, and deploying advanced AI tools to improve efficiency and cost control. FedEx has also gained recognition for an e-waste circular economy pilot, highlighting a broader push into sustainability within its logistics...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Is Columbia Banking System (COLB) Pricing Reflect Long Term Value After Recent Share Price Gains

If you are wondering whether Columbia Banking System's current share price lines up with its underlying value, this article will walk through the key pieces you need to look at. The stock recently closed at US$31.24, with returns of 8.1% over the last 30 days and 19.9% over the past year, which may have shifted how investors view its growth prospects and risk. Recent headlines around Columbia Banking System have largely focused on broader sector themes and company specific updates that...
NYSE:WLY
NYSE:WLYMedia

Does Wiley’s Advanced Portfolio Expansion Into Life Sciences Reshape The Bull Case For John Wiley & Sons (WLY)?

In February 2026, John Wiley & Sons announced a major expansion of its Advanced Portfolio, planning to launch eight new life, health, and social sciences journals by the end of 2026, starting with Advanced Oncology opening for submissions shortly after the announcement. This move turns the Advanced Portfolio from a materials science specialist into a broader multidisciplinary platform, aiming to give researchers a streamlined, single-submission publishing experience across physical, life,...
NYSE:FDP
NYSE:FDPFood

Fresh Del Monte Produce (FDP) Earnings Hit One Off Loss That Fuels Margin Debate

Fresh Del Monte Produce (FDP) has reported a mixed set of FY 2025 numbers, with Q3 revenue of US$1.0b and a basic EPS loss of US$0.61, set against trailing 12 month EPS of US$1.65 and net income of US$79.2m. The company has seen quarterly revenue move between US$1.0b and US$1.2b over the last six reported periods, while basic EPS has ranged from a loss of US$0.61 to a high of US$1.18. The latest quarter therefore lands at the weaker end of that spectrum and leaves investors focused on how...
NYSE:CHE
NYSE:CHEHealthcare

Assessing Chemed (CHE) Valuation After New US$300 Million Buyback And Ongoing Dividend Streak

Chemed (CHE) has put shareholder returns back in focus after boosting its equity buyback authorization by US$300 million and reaffirming a US$0.60 quarterly dividend, maintaining a long running payout record. See our latest analysis for Chemed. Those buyback and dividend decisions come after a solid 90 day share price return of 8.93% and a 10.35% year to date share price gain, even though the 1 year total shareholder return is 15.45% lower. This suggests that recent momentum contrasts with...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

Is It Time To Reassess CoreWeave (CRWV) After AI Infrastructure Backlog Headlines?

If you are asking yourself whether CoreWeave is fairly priced at its current level, this article will walk you through what the numbers suggest about that question. The stock recently closed at US$95.45, with a 0.3% return over 7 days, a 5.7% decline over 30 days and a 20.3% gain year to date. These moves may signal changing views on both its growth potential and risk. Recent headlines have focused on CoreWeave's position in AI infrastructure and cloud services, as investors continue to...
NYSE:AWR
NYSE:AWRWater Utilities

How Investors May Respond To American States Water (AWR) Earnings, Dividend Hike, And Infrastructure Spending Plan

In the past week, American States Water Company reported fourth-quarter 2025 sales of US$164.28 million and net income of US$28.74 million, alongside full-year 2025 revenue of US$658.07 million and earnings per share of US$3.37 from continuing operations. The company paired this steady profit performance with another quarterly dividend increase to US$0.5040 per share and plans for substantial, regulator-supported infrastructure investment, underscoring its focus on long-term capital...
NasdaqGS:LCID
NasdaqGS:LCIDAuto

Lucid Group Leans Into Autonomous Software Partnerships As Fleet Risks Mount

Lucid Group (NasdaqGS:LCID) is shifting its long term focus toward software and autonomous driving partnerships, aiming to prioritize software and AI development over pure vehicle sales. The company has entered a major partnership with Uber and Nuro to deploy a large fleet of autonomous premium EVs, supported by a substantial investment from Uber. Lucid is making several high level executive appointments to strengthen global supply chain and engineering leadership as it works to execute this...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

Assessing AST SpaceMobile (ASTS) Valuation After Convertible Notes Deal And BlueBird 6 Milestone

AST SpaceMobile (ASTS) has put two big issues on the table at once: a US$1b low coupon convertible notes deal that reshapes its capital structure, and the successful deployment of its BlueBird 6 satellite. See our latest analysis for AST SpaceMobile. Those financing moves and the BlueBird 6 deployment come after a volatile run, with a 66.53% 3 month share price return and a very large 3 year total shareholder return of about 13x. However, recent 1 month and 7 day share price declines suggest...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Is Revolution Medicines (RVMD) Pricing In Pipeline Progress After A 135.7% One Year Surge?

If you are wondering whether Revolution Medicines at around US$99.79 is priced for its future potential or getting ahead of itself, you are in the right place for a clear look at what the current valuation is really telling you. The stock has had a mixed run recently, with a 1.8% gain over the last 7 days, a 17.0% decline over the past month, a 26.3% year to date return, and 135.7% over the last year, along with a very large 3 year return that sits just under 3x. These moves sit against a...
NYSE:ASGN
NYSE:ASGNIT

Assessing ASGN (ASGN) Valuation After Federal Leadership Move And New Cloud FinOps Partnership

ASGN (ASGN) has returned to focus after appointing federal services veteran Donnie Scott to lead its Federal Segment and announcing a new cloud FinOps partnership between Apex Systems and Cloudaware targeting enterprise cost management needs. See our latest analysis for ASGN. The latest management changes and cloud partnership arrive as ASGN’s 1-day share price return of 4.53% contrasts with a 30-day share price return decline of 11.95% and a 1-year total shareholder return loss of 40.56%...
NYSE:AVA
NYSE:AVAIntegrated Utilities

Assessing Avista (AVA) Valuation After Idaho Electricity Rate Increase Request

Idaho rate case puts Avista (AVA) in focus Avista (AVA) has filed for an annual electric rate adjustment with the Idaho Public Utilities Commission, seeking a 7.4% revenue increase tied to funding electric energy efficiency programs. See our latest analysis for Avista. Avista’s recent Idaho rate case comes as the stock’s share price return is up 4.95% over 30 days and 8.91% year to date, while its 1 year total shareholder return of 18.58% points to steady, if moderate, momentum rather than a...
NYSE:KSS
NYSE:KSSMultiline Retail

Did Kohl’s New Under‑$10 “Deal Bar” Just Shift Kohl's (KSS) Investment Narrative?

Kohl’s recently introduced a new “Deal Bar” section at the front of all its stores, offering gifts, seasonal items, and everyday essentials priced at US$10 or less to appeal to cost-conscious shoppers. This move underlines Kohl’s push to revive store traffic by foregrounding sharply priced impulse and necessity purchases as consumers trim discretionary spending. Next, we’ll examine how the new under-US$10 Deal Bar concept could influence Kohl’s turnaround-focused investment narrative and...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Why Rivian (RIVN) Is Up 15.4% After Mixed Q4 Results And A VW-Funded Tech Pivot

Rivian Automotive reported fourth-quarter 2025 revenue of US$1,286 million, down from US$1,734 million a year earlier, with a net loss of US$811 million, while full-year revenue rose to US$5,387 million and the annual net loss narrowed to US$3,646 million. Alongside these results, Rivian filed a US$1.10 billion shelf registration for ESOP-related Class A shares and highlighted growing software revenue and funding from its Volkswagen joint venture, underscoring its shift toward a technology...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

How Weaker Results And All-Free-Cash-Flow Buybacks At ON (ON) Have Changed Its Investment Story

In February 2026, ON Semiconductor reported fourth-quarter 2025 sales of US$1,530.1 million and net income of US$181.8 million, while full-year 2025 sales reached US$5,995.4 million with net income of US$121 million, alongside first-quarter 2026 guidance for revenue of US$1,435 million to US$1,535 million and diluted EPS of US$0.28 to US$0.38. At the same time, the company underscored growing AI data center demand, stabilization in automotive and industrial markets, and a commitment to...
NYSE:HIMS
NYSE:HIMSHealthcare

Is Hims & Hers Health (HIMS) Now Attractive After Sharp Share Price Pullback?

If you are wondering whether Hims & Hers Health at around US$15.84 is starting to look attractive, you are not alone in asking what the current price really gets you. The share price has pulled back sharply, with a 5.1% decline over the last 7 days, a 49.5% decline over the last 30 days, and a 52.6% decline year to date, even though the 3 year return sits at 70.5%. Over the past year, the stock has also recorded a 77.0% decline, and the 5 year return stands at a 5.9% decline, which has...
NasdaqGS:GH
NasdaqGS:GHHealthcare

Is FDA and Reimbursement Momentum Altering The Investment Case For Guardant Health (GH)?

In the days leading up to its recent earnings release, Guardant Health, a liquid biopsy specialist, drew increased attention after previously reporting US$265.2 million in quarterly revenue, up strongly year on year and ahead of analyst expectations. Institutional investors have been highlighting Guardant Health’s progress on FDA submissions, reimbursement expansion, and margin improvement, which together suggest meaningful operational momentum despite ongoing concerns about scale and...
NYSE:SHW
NYSE:SHWChemicals

Sherwin-Williams Labor Lawsuit Tests Employment Practices And Investor Risk Outlook

Sherwin-Williams (NYSE:SHW) is facing a new class action lawsuit in California. The suit alleges violations of labor laws, including unpaid minimum and overtime wages. Claims also include denial of required meal and rest breaks and related wage and hour issues. The case raises questions about employment practices and potential legal liabilities for the company. Sherwin-Williams, a major paints and coatings producer, is closely tied to housing, construction, and maintenance activity. Many...
NYSE:PLD
NYSE:PLDIndustrial REITs

Assessing Prologis (PLD) Valuation After Toxic Gas Verdict And Growing Legal Liabilities

A recent Los Angeles jury verdict tied to toxic hydrogen sulfide gas exposure at a Prologis (PLD) warehouse has put the company’s legal risks in focus, with multimillion dollar damages and thousands of related claims pending. See our latest analysis for Prologis. At a share price of $139.63, Prologis has seen a 13.41% 90 day share price return and an 18.89% 1 year total shareholder return, suggesting positive momentum as the recent legal verdict and a 6% dividend increase reshape how...
NYSE:AES
NYSE:AESRenewable Energy

Is It Too Late To Consider AES (AES) After A 66% One Year Rally?

Wondering if AES at US$16.29 is still offering value after its recent run, or if the easy money has already been made? This article is here to help you size that up calmly and clearly. The stock has returned 14.8% over the last 30 days and 65.6% over the last year, while the 3-year and 5-year returns of 26.4% and 29.7% declines show that the longer term picture has been very different. Recent news flow around AES has focused on its position in US utilities, including how investors are...
NYSE:WKC
NYSE:WKCOil and Gas

Will Recurring EPS Misses And A 2026 CEO Shift Change World Kinect's (WKC) Narrative

World Kinect Corporation recently reported Q4 EPS of US$0.54, missing analyst estimates by 11% for a third straight quarter amid ongoing margin pressure and revenue declines, while confirming that CFO and President Ira Birns will take over as CEO from 1 January 2026. This combination of recurring earnings disappointments, leadership change, and management’s interest in acquisitions to support EPS has sharpened questions about the company’s ability to rely on its core operations for future...
NYSE:IMAX
NYSE:IMAXEntertainment

IMAX (IMAX) Valuation Check As Exclusive Elvis And Tommy Events Draw Premium Cinema Fans

IMAX (IMAX) is back in the spotlight as it prepares an exclusive theatrical debut for Baz Luhrmann’s Elvis Presley concert documentary, alongside two-day 50th anniversary IMAX screenings of The Who’s rock opera film Tommy. See our latest analysis for IMAX. At a share price of US$37.80, IMAX has logged a 6.78% 3 month share price return and a 38.87% 1 year total shareholder return, and recent box office events and premium content partnerships appear to be contributing to gradually building...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

Viper Energy Refocuses On Permian Royalties As Valuation Debate Grows

Viper Energy (NasdaqGS:VNOM) is acquiring Sitio Royalties, expanding its royalty footprint in US shale. The company plans to sell its non Permian assets, sharpening its focus on its core basin. Management is working on integrating Sitio's assets into Viper's no capex royalty model. Analysts are highlighting how the combined royalty portfolio could affect future cash generation and distributions. Viper Energy, trading at $44.61, has seen its share price move 20.8% over the past month and...